Literature DB >> 1912258

Procedures for two-sample comparisons with multiple endpoints controlling the experimentwise error rate.

W Lehmacher1, G Wassmer, P Reitmeir.   

Abstract

Clinical trials are often concerned with the comparison of two treatment groups with multiple endpoints. As alternatives to the commonly used methods, the T2 test and the Bonferroni method, O'Brien (1984, Biometrics 40, 1079-1087) proposes tests based on statistics that are simple or weighted sums of the single endpoints. This approach turns out to be powerful if all treatment differences are in the same direction [compare Pocock, Geller, and Tsiatis (1987, Biometrics 43, 487-498)]. The disadvantage of these multivariate methods is that they are suitable only for demonstrating a global difference, whereas the clinician is further interested in which specific endpoints or sets of endpoints actually caused this difference. It is shown here that all tests are suitable for the construction of a closed multiple test procedure where, after the rejection of the global hypothesis, all lower-dimensional marginal hypotheses and finally the single hypotheses are tested step by step. This procedure controls the experimentwise error rate. It is just as powerful as the multivariate test and, in addition, it is possible to detect significant differences between the endpoints or sets of endpoints.

Mesh:

Year:  1991        PMID: 1912258

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  22 in total

1.  Measuring outcome in traumatic brain injury treatment trials: recommendations from the traumatic brain injury clinical trials network.

Authors:  Emilia Bagiella; Thomas A Novack; Beth Ansel; Ramon Diaz-Arrastia; Sureyya Dikmen; Tessa Hart; Nancy Temkin
Journal:  J Head Trauma Rehabil       Date:  2010 Sep-Oct       Impact factor: 2.710

2.  Permutation criteria to evaluate multiple clinical endpoints in a proof-of-concept study: lessons from Pre-RELAX-AHF.

Authors:  Beth A Davison; Gad Cotter; Hengrui Sun; Li Chen; John R Teerlink; Marco Metra; G Michael Felker; Adriaan A Voors; Piotr Ponikowski; Gerasimos Filippatos; Barry Greenberg; Sam L Teichman; Elaine Unemori; Gary G Koch
Journal:  Clin Res Cardiol       Date:  2011-03-17       Impact factor: 5.460

3.  A randomized trial testing the superiority of a postdischarge care management model for stroke survivors.

Authors:  Kyle Allen; Susan Hazelett; David Jarjoura; Keding Hua; Kathy Wright; Janice Weinhardt; Denise Kropp
Journal:  J Stroke Cerebrovasc Dis       Date:  2009 Nov-Dec       Impact factor: 2.136

4.  Using global statistical tests in long-term Parkinson's disease clinical trials.

Authors:  Peng Huang; Christopher G Goetz; Robert F Woolson; Barbara Tilley; Douglas Kerr; Yuko Palesch; Jordan Elm; Bernard Ravina; Kenneth J Bergmann; Karl Kieburtz
Journal:  Mov Disord       Date:  2009-09-15       Impact factor: 10.338

5.  Bayesian multiple imputation for missing multivariate longitudinal data from a Parkinson's disease clinical trial.

Authors:  Sheng Luo; Andrew B Lawson; Bo He; Jordan J Elm; Barbara C Tilley
Journal:  Stat Methods Med Res       Date:  2012-12-12       Impact factor: 3.021

6.  Workplace based mindfulness practice and inflammation: a randomized trial.

Authors:  William B Malarkey; David Jarjoura; Maryanna Klatt
Journal:  Brain Behav Immun       Date:  2012-10-16       Impact factor: 7.217

7.  Can lifestyle modification improve neurocognition? Rationale and design of the ENLIGHTEN clinical trial.

Authors:  James A Blumenthal; Patrick J Smith; Kathleen Welsh-Bohmer; Michael A Babyak; Jeffrey Browndyke; Pao-Hwa Lin; P Murali Doraiswamy; James Burke; William Kraus; Alan Hinderliter; Andrew Sherwood
Journal:  Contemp Clin Trials       Date:  2012-09-19       Impact factor: 2.226

8.  Closed Testing in Pharmaceutical Research: Historical and Recent Developments.

Authors:  Kevin S S Henning; Peter H Westfall
Journal:  Stat Biopharm Res       Date:  2015       Impact factor: 1.452

9.  Lack of prophylactic or therapeutic efficacy of 5-HT2A receptor antagonists in halothane-induced porcine malignant hyperthermia.

Authors:  W Löscher; C Gerdes; A Richter
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-10       Impact factor: 3.000

10.  The South Asian Healthy Lifestyle Intervention (SAHELI) trial: Protocol for a mixed-methods, hybrid effectiveness implementation trial for reducing cardiovascular risk in South Asians in the United States.

Authors:  Namratha R Kandula; Veronica Bernard; Swapna Dave; Linda Ehrlich-Jones; Catherine Counard; Nirav Shah; Santosh Kumar; Goutham Rao; Ronald Ackermann; Bonnie Spring; Juned Siddique
Journal:  Contemp Clin Trials       Date:  2020-03-24       Impact factor: 2.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.